2012 Safety Side effects 
Pharmaceutical Technology
MAY 25, 2023
The biobank will work in parallel with the MHRA’s Yellow Card website, which is used for reporting adverse events and side effects caused by medicines and medical devices, per the 25 May announcement. According to the press release, the MHRA will be the first drug safety regulator in the world to pilot such a biobank.
European Pharmaceutical Review
OCTOBER 10, 2022
Since 2012, the CDC has recommended the vaccine series during the third trimester of each pregnancy. Side effect data related to those given the non-US variation during pregnancy was consistent with data for individuals who were given the non-US formulation post labour.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 12, 2024
The main objective was to evaluate the efficacy and safety of MBK-01 compared to fidaxomicin, providing significant insights into the potential of MBK-01 as a treatment for primary or recurrent CDI and contributing to the advancement of microbiome-based therapies. 2012; 18 (6): 21-27. percent for MBK-01 and 4.26 Intern Med J.
European Pharmaceutical Review
OCTOBER 17, 2024
Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. Hand (N Y). 2007; 2(1):5-11.
Pharmaceutical Technology
JANUARY 27, 2023
As for Briumvi’s side effects, around 45% of patients experienced infections of the upper respiratory tract, which was 4% higher in comparison to Aubagio. All three treatments are monoclonal antibodies. Some 48% of patients on Briumvi also suffered with infusion reactions.
Contrarian Sales Techniques
FEBRUARY 26, 2023
There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. There are some countries in the world that do not require waiting for patent expiration to produce a generic version of a drug.
European Pharmaceutical Review
JULY 20, 2022
Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. Supporting regulators. It focused on data from France, Germany and the UK.
Expert insights. Personalized for you.
52 
Let's personalize your content